Suchen und Finden

Titel

Autor

Inhaltsverzeichnis

Nur ebooks mit Firmenlizenz anzeigen:

 

The Comparative Effectiveness of Cytology Testing and HPV DNA Testing Based Primary Screening Pathways within a Cervical Screening Program

The Comparative Effectiveness of Cytology Testing and HPV DNA Testing Based Primary Screening Pathways within a Cervical Screening Program

Patrick Kimuyu

 

Verlag GRIN Verlag , 2018

ISBN 9783668623163 , 13 Seiten

Format PDF

Kopierschutz frei

Geräte

12,99 EUR

Für Firmen: Nutzung über Internet und Intranet (ab 2 Exemplaren) freigegeben

Derzeit können über den Shop maximal 500 Exemplare bestellt werden. Benötigen Sie mehr Exemplare, nehmen Sie bitte Kontakt mit uns auf.

Mehr zum Inhalt

The Comparative Effectiveness of Cytology Testing and HPV DNA Testing Based Primary Screening Pathways within a Cervical Screening Program


 

Literature Review from the year 2018 in the subject Medicine - Diagnostics, grade: 1, Egerton University, language: English, abstract: Primary screening of cervical cancer has been faced with an array of challenges which are attributable to the lack of appropriate technology. These challenges compromised the effectiveness of screening programs in different countries. It is apparent that the detection of cervical cancer precursors forms the basis for the success of screening programs for cervical cancer leading to the reduction of cervical cancer incidence and prevalence trends. Currently, there are two diagnostic methods that can be used for primary screening of cervical cancer: Pap cytology and HPV DNA test. However, the comparative effectiveness of this diagnostic tests indicate that HPV test is more effective than Pap cytology which is used as a first-line diagnostic method in cervical cancer prevention programs in many countries. Cytology testing and HPV testing differ significantly on the level of accuracy and sensitivity. Evidence studies indicate that HPV test exhibits high sensitivity and accuracy compared to Pap test. In a publicly-financed healthcare system such as the US, Canadian and EU, HPV testing has been proven to be more cost-effective than Pap test. Therefore, there is need to adopt HPV test for triage and primary screening.